Patents by Inventor Allyson Gage

Allyson Gage has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS FOR TREATING NEUROPATHIC PAIN
    Publication number: 20110190347
    Abstract: The present invention relates to methods of treating diabetic neuropathic pain comprising administering piperidine derivatives, such as 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzoxazol-6-yl)acetamide, and pharmaceutically acceptable salts thereof. Methods of treating post-herpetic neuralgia, chronic lower back pain, osteoarthritis and acute inflammatory pain are described.
    Type: Application
    Filed: August 21, 2009
    Publication date: August 4, 2011
    Applicant: RICHTER GEDEON NYRT.
    Inventor: Allyson Gage
  • METHODS FOR TREATING NEUROPATHIC PAIN
    Publication number: 20100048629
    Abstract: The present invention relates to methods of treating diabetic neuropathic pain comprising administering piperidine derivatives, such as 2-[4-(4-fluoro-benzyl)-piperidine-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzoxazol-6-yl)acetamide, and pharmaceutically acceptable salts thereof. Methods of treating post-herpetic neuralgia, chronic lower back pain, osteoarthritis and acute inflammatory pain are described.
    Type: Application
    Filed: August 21, 2009
    Publication date: February 25, 2010
    Inventor: Allyson Gage
  • Memantine as adjunctive treatment to atypical antipsychotic in schizophrenia patients
    Publication number: 20060035888
    Abstract: The present invention provides a method for treating schizophrenia in a patient in need thereof, the method comprising administering to the patient a therapeutically effective amount of memantine, or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount an atypical antipsychotic. The method of the present invention embodies both the co-administration of memantine with an atypical antipsychotic, and the use of memantine as an adjunctive treatment to treatment with an atypical antipsychotic.
    Type: Application
    Filed: July 7, 2005
    Publication date: February 16, 2006
    Applicant: Forest Laboratories, Inc.
    Inventors: Jeffrey Jonas, Allyson Gage